NE BUSINESS BUREAU
NEW DELHI, OCT 4
Drug firm Zydus Healthcare on Sunday said it has launched generic anti-diabetic Dapagliflozin tablets across the country under the brand name ”Dapaglyn” at a highly affordable price to increase patient access.
The company has launched its Dapagliflozin tablets in the strengths of 10 mg and 5 mg priced at Rs 17 and Rs 14, respectively, in India upon patent expiry of the product, Zydus Healthcare said in a statement.
“In keeping with its efforts to make therapies accessible and affordable to patients, the drug will be highly economical, priced at 1/3rd the cost than currently available Dapagliflozin brands in India,” it added.
The once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes mellitus, Zydus Healthcare said.
Dapagliflozin is part of a newer class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, it added.
